Clinical Trials Directory

Trials / Unknown

UnknownNCT05162079

Protocol for the ESREFLUJO Study: Epidemiological Study of Heartburn and Gastroesophageal Reflux in Community Pharmacy

Status
Unknown
Phase
Study type
Observational
Enrollment
1,200 (estimated)
Sponsor
Universidad Miguel Hernandez de Elche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Introduction: Symptoms as heartburn and/or reflux is frequent consultations in community pharmacies, the characterization of them is crucial to provide appropriate patient counseling. To facilitate the assistance work of the community pharmacist and its coordination between different levels of care, a group of experts in Community Pharmacy, Primary Care, and Gastroenterology has recently worked on an algorithm to manage these symptoms. Objective: Analyse the epidemiological characteristics of patients who consult for symptoms of heartburn and/or reflux in Spanish community pharmacies, and evaluate the clinical and humanistic results of the protocolization of a Professional Pharmaceutical Service in said patients. Methods and analysis: The study design consists of a cross-sectional descriptive part, in which the clinical and sociodemographic characteristics of the patients who come to the community pharmacy will be evaluated for consultation derived from heartburn and/or reflux symptoms and a before-after descriptive study in which will evaluate the clinical and humanistic results in patients who come to the pharmacy after receiving pharmaceutical care.

Conditions

Timeline

Start date
2022-03-01
Primary completion
2022-07-01
Completion
2022-09-01
First posted
2021-12-17
Last updated
2021-12-17

Source: ClinicalTrials.gov record NCT05162079. Inclusion in this directory is not an endorsement.